ClearPoint Neuro, Inc.

18.88-0.4300-2.23%Vol 237.31K1Y Perf 358.14%
Jun 18th, 2021 16:00 DELAYED
BID18.80 ASK18.95
Open19.05 Previous Close19.31
Pre-Market- After-Market-
 - -  - -%
Target Price
35.00 
Analyst Rating
— — 0.00
Potential %
85.38 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     39.59
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.67
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap391.97M 
Earnings Rating
Price Range Ratio 52W %
55.90 
Earnings Date
11th Aug 2021

Today's Price Range

18.6619.37

52W Range

3.1531.29

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-4.11%
1 Month
1.56%
3 Months
-5.69%
6 Months
45.23%
1 Year
358.14%
3 Years
742.86%
5 Years
105.22%
10 Years
-

TickerPriceChg.Chg.%
CLPT18.88-0.4300-2.23
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Financial StrengthValueIndustryS&P 500US Markets
2.70
3.60
0.24
0.34
-4.40
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
65.50
-48.20
-46.30
-126.10
-54.23
RevenueValueIndustryS&P 500US Markets
7.36M
0.47
8.95
16.38
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.15-0.1313.33
Q04 2020-0.13-0.0930.77
Q03 2020-0.14-0.0935.71
Q02 2020-0.16-0.1131.25
Q01 2020-0.18-0.1327.78
Q04 2019--0.11-
Q03 2019--0.08-
Q02 2019--0.13-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Aug 2021
Estimated EPS Next Report-0.14
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume237.31K
Shares Outstanding20.76M
Trades Count3.69K
Dollar Volume10.93M
Avg. Volume407.08K
Avg. Weekly Volume290.77K
Avg. Monthly Volume338.77K
Avg. Quarterly Volume368.07K

ClearPoint Neuro, Inc. (NASDAQ: CLPT) stock closed at 18.88 per share at the end of the most recent trading day (a -2.96% change compared to the prior day closing price) with a volume of 237.41K shares and market capitalization of 391.97M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 38 people. ClearPoint Neuro, Inc. CEO is Joseph M. Burnett.

The one-year performance of ClearPoint Neuro, Inc. stock is 358.14%, while year-to-date (YTD) performance is 18.82%. CLPT stock has a five-year performance of 105.22%. Its 52-week range is between 3.15 and 31.29, which gives CLPT stock a 52-week price range ratio of 55.90%

ClearPoint Neuro, Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 8.01, a price-to-sale (PS) ratio of 40.81, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -43.59%, a ROC of -49.18% and a ROE of -103.51%. The company’s profit margin is -54.23%, its EBITDA margin is -46.30%, and its revenue ttm is $7.36 Million , which makes it $0.47 revenue per share.

Of the last four earnings reports from ClearPoint Neuro, Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. ClearPoint Neuro, Inc.’s next earnings report date is 11th Aug 2021.

The consensus rating of Wall Street analysts for ClearPoint Neuro, Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for ClearPoint Neuro, Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ClearPoint Neuro, Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ClearPoint Neuro, Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 48.66, ATR14 : 1.20, CCI20 : 11.52, Chaikin Money Flow : -0.19, MACD : 0.09, Money Flow Index : 53.51, ROC : 4.77, RSI : 47.83, STOCH (14,3) : 28.72, STOCH RSI : 0.00, UO : 41.02, Williams %R : -71.28), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ClearPoint Neuro, Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

ClearPoint Neuro, Inc.

MRI Interventions Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System.

CEO: Joseph M. Burnett

Telephone: +1 949 900-6833

Address: 5 Musick, Irvine 92618, CA, US

Number of employees: 38

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits